Biogen Idec establishes new international HQ in Switzerland

Published: 7-Jul-2004


US biotech company Biogen Idec has officially opened its new international headquarters in Zug, Switzerland. The offices, which are scheduled to be fully staffed by the end of 2004, are expected to have approximately 50 employees and support Biogen Idec's international operations.

These include:

• operations in Australia, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Luxembourg, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, and the UK;

• a European regulatory and clinical centre of excellence in Maidenhead, UK;

• a European packaging and logistics centre of excellence in Hoofddorp, Netherlands; and

• a worldwide distribution network covering 79 markets in Latin America, Central and Eastern Europe, Africa, and Asia.

'Switzerland's skilled workforce and pro-business climate will strengthen our position as one of the few biotechnology companies with global operations,' said Biogen Idec's ceo James C. Mullen. 'As we partner with other companies and continue to develop our pipeline, the Zug headquarters will be key in co-ordinating our international commercial operations for maximum efficiency.'

Biogen Idec has also announced today that it is re-starting construction of its large-scale biologic manufacturing facility in Hillerod, Denmark. The 90,000-litre facility will be used to manufacture products in the pipeline and will bring Biogen Idec's global large-scale manufacturing capacity to 270,000 litres. Biogen Idec expects to invest US$340m to build the facility, which will generate approximately 200 jobs. The facility is expected to be available for commercial production in 2008.

  

See more

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

Read more
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Research & Development

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Manufacturing

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
Manufacturing

L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
Subscribe now